Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRR12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOSIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FCGRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD35B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on